During the past decade, many clinical data have revealed that the overexpression of HPSE correlates with reduced postoperative survival and poorer prognosis of colorectal, pancreatic, bladder, gastric, and cervical cancer patients [24]–[28]. The gene discussed is HPSE; the disease is cervical cancer.